Kyprianou K, Pericleous A, Stavrou A, Dimitrakaki IA, Challoumas D, Dimitrakakis G. Surgical perspectives in the management of atrial fibrillation. World J Cardiol 2016; 8(1): 41-56 [PMID: 26839656 DOI: 10.4330/wjc.v8.i1.41]
Corresponding Author of This Article
Georgios Dimitrakakis, MD, MSc, Department of Cardiothoracic Surgery, University Hospital of Wales, Heath Park Campus, Cardiff CF14 4XW, United Kingdom. gdimitrakakis@yahoo.com
Research Domain of This Article
Surgery
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Jan 26, 2016; 8(1): 41-56 Published online Jan 26, 2016. doi: 10.4330/wjc.v8.i1.41
Table 1 The five types of atrial fibrillation as classified by European Heart Rhythm Association and European Association For Cardio Thoracic Surgery
Type of AF
Duration
Definition
First diagnosis
-
First episode of AF irrespective to duration or severity
Paroxysmal
48 h
Self-terminating (usually within 48 h); may continue for up to 7 d. After 48 h it is unlikely that spontaneous conversion will occur
Anticoagulation must be considered
Persistent
> 7 d
Requires termination by cardio-eversion with drugs or direct current
Long standing persistent
≥ 1 yr
Rhythm control strategy
Permanent
-
Presence of arrhythmia is accepted and rhythm control interventions are not pursued1
Table 2 Comparing and contrasting the various available ablation modalitie
Ablationmodality
Mode of action
Advantages
Complications
Transmural lesions
Current limitations
RFA
Controlled thermal damage and lesions caused by electrical current
Less operating time Reduced technical difficulty
Intercavity thrombus Pulmonary vein stenosis Oesophageal and coronary artery injury
Variable
Confirmation of transmurality Variation between instruments
Cryoablation
Targeted scarring by cooling tissue using high-pressure argon and helium Initial cellular destruction followed by fibrosis and full thickness disruption
Visual confirmation of transmurality Less damage to surrounding tissues and vascularity Less endocardial thrombus Electrical isolation of atria
Coronary artery and phrenic nerve injury Atrioesophageal fistula
Yes
Variable success rate
Microwave
Production of lesions by thermal injury
Minimal collateral damage Minimal scar formation Lower risk of VTE
Coronary artery damage potential
Variable
Less effective compared to other modalities Limited evidence
HIFU
Creation of localised hyperthermic lesions using a focused beam of ultrasound energy
Fast epicardial lesions Future potential advantage visualisation of thickness by ultrasound and tailor made lesions
High rate of complications Limited evidence currently not recommended outside trials
Laser
Use of high energy optical beams to create thermal lesions
Well demarcated lesions Non-arrythmogenic Rapid lesions
Crater formation Perforation Tissue loss Poor visibility of scar
Yes
Limited evidence currently not recommended outside trials
Table 3 Adapted from 2012 Heart Rhythm Society/European Heart Rhythm Association/European Society of Cardiology guidelines
Indications for concomitant surgical ablation of AF
Symptomatic AF refractory or intolerant to at least one Class 1 or 3 antiarrhythmic medication
Paroxysmal: Surgical ablation is reasonable for patients undergoing surgery for other indications (IIa, C)
Persistent: Surgical ablation is reasonable for patients undergoing surgery for other indications (IIa, C)
Longstanding persistent: Surgical ablation is reasonable for patients undergoing surgery for other indications (IIa, C)
Symptomatic AF prior to initiation of antiarrhythmic drug therapy with a Class 1 or 3 antiarrhythmic agent
Paroxysmal: Surgical ablation is reasonable for patients undergoing surgery for other indications (IIa, C)
Persistent: Surgical ablation is reasonable for patients undergoing surgery for other indications (IIa, C)
Longstanding persistent: Surgical ablation may be considered for patients undergoing surgery for other indications (IIb, C)
Indications for standing alone surgical ablation of AF
Symptomatic AF refractory or intolerant to at least one Class 1 or 3 antiarrhythmic medication
Paroxysmal: Stand alone surgical ablation may be considered for patients who have not failed catheter ablation but prefer a surgical approach (IIb, C)
Paroxysmal: Stand alone surgical ablation may be considered for patients who have failed one or more attempts at catheter ablation (IIb, C)
Persistent: Stand alone surgical ablation may be considered for patients who have not failed catheter ablation but prefer a surgical approach (IIb, C)
Persistent: Stand alone surgical ablation may be considered for patients who have failed one or more attempts at catheter ablation (IIb, C)
Longstanding persistent: Stand alone surgical ablation may be considered for patients who have not failed catheter ablation but prefer a surgical approach (IIb, C)
Longstanding persistent: Stand alone surgical ablation may be considered for patients who have failed one or more attempts at catheter ablation (IIb, C)
Symptomatic AF prior to initiation of antiarrhythmic drug therapy with a Class 1 or 3 antiarrhythmic agent
Paroxysmal: Stand alone surgical ablation is not recommended (III, C)
Persistent: Stand alone surgical ablation is not recommended (III, C)
Longstanding persistent: Stand alone surgical ablation is not recommended (III, C)
Table 4 Adapted from the surgical treatment of atrial fibrillation guidelines by the European Association for Cardio-Thoracic Surgery Clinical Guidelines Committee guidelines
Use of ablative modalities
Unipolar radiofrequency ablation
Concomitant unipolar RFA for AF treatment together with cardiac surgery is effective in restoration of sinus rhythm
Success rates vary between 54%-83% at medium term follow up (at least 12 mo)
Safe procedure - no additional risks
Success rates are higher with: paroxysmal or persistent AF, younger age, smaller LAD
Class IIa recommendation based on multiple small retrospective studies (Level C)
Bipolar radiofrequency ablation
Higher success rates in restoring sinus rhythm compared to no ablation in concomitant cardiac surgery
On average the cross clamp time is increased by 15 min
There is limited evidence to suggest superiority of bipolar over unipolar RFA
1 prospective trial has provided evidence demonstrating superiority of bipolar RFA over microwave ablation
Class I recommendation based on 3 RCTs and multiple small prospective studies (Level A)
Cryoablation
Acceptable intervention for AF treatment during concomitant surgery with acceptable sinus rhythm conversion rates between 60%-82% at 12 mo
Cryoablation is most successful in patients suffering from paroxysmal as opposed to permanent AF (suggested by 6 out of 9 studies reviewed)
Class IIa recommendation based on 1 small RCT and multiple prospective and retrospective studies (Level B)
Microwave ablation
Less effective intervention for AF treatment based on the limited evidence
Success rates in the longer term are less clear - the only RCT to date has found outcomes inferior to RFA
Class III recommendation based on 1 small RCT and multiple small prospective and retrospective studies (Level B)
HIFU
Currently not recommended as an intervention for the treatment of AF during concomitant surgery outside clinical trials due to limited evidence
Success rates seem to be inferior to those of other devices
Significant concerns have been reported
Class III recommendation based on cohort studies (Level C)
Exclusion of laa and standing alone surgical ablation
Exclusion of LAA
No proven benefit of surgical LAA exclusion in terms of stroke reduction or mortality
Ineffective LAA occlusion and potentially increased stroke risk due to poor technique was seen in many studies
Devices designed for LAA exclusion should be preferentially used rather than a cut and sew or stapling technique, if LAA is to be performed
Class IIa recommendation based on multiple cohort studies and one pilot RCT (Level B)
Stand alone surgical ablation
Surgery can be considered for symptomatic patients who are refractory or intolerant to at least 1 anti-arrhythmic medication
Considered for patients with paroxysmal, long standing and persistent AF who prefer surgery to catheter ablation or have failed catheter ablation
Results of both catheter-based and surgery-based ablation should be discussed with the patient
Class IIa recommendations based on 1 RCT and multiple cohort studies (Level B)
Table 5 Summary of results from studies included looking at Cox-Maze procedures
Successful LAA closure 73% with surgical excision and 23% with suture exclusion. Evidence of stroke in 11% of successful LAA closure and 15% of unsuccessful LAA closure (P = 0.61)
High proportion of surgical LAA closure. LAA excision more successful than exclusion
Return to sinus rhythm 29% 57% and 75% (at discharge, 3 mo and 12 mo post-procedure) in the cardioblate group vs 20%, 43% and 29% respectively in the control group
Concomitant RFA resulted in 75% conversion rate to sinus rhythm compared to the control group (39%)
Multicentre RCT involving 224 patients with AF undergoing cardiac surgery with ( n = 117) or without ablation (n = 107)
30 d
At 1 yr follow up, 60.2% of patients were in sinus rhythm in the ablation group compared to 35.5% in the control group. 1 yr mortality was 16.2% and 17.4% respectively
Concomitant ablation increases postoperative sinus rhythm with no effect on peri-operative complications
Double-blind randomized study of 69 patients undergoing mitral valve surgery with or without epicardial left atrial cryoablation
6 and 12 mo
At 6 mo follow-up, 73.3% of patients in the cryoablation group regained sinus rhythm vs 45.7% of patients with mitral valve surgery alone (P = 0.024). At 12 mo follow-up, the results were 73.3% vs 42.9% respectively (P = 0.013)
Concomitant left atrial epicardial cardioablation is significantly better in regaining sinus rhythm in patients with permanent AF compared to mitral valve surgery alone
Prospective, multicentre, double-blinded RCT involving 43 patients with mitral valve disease and permanent AF
12 mo
At 12 mo, sinus rhythm was maintained without any arrhythmia recurrences in 57% of patients in the RFA group vs 4% in the control group (undergoing mitral valve surgery only)
Left atrial RFA is an effective procedure in patients suffering with long-term AF and co-existing valvular disease
100 patients in paroxysmal or persistent AF undergoing cardiac surgery were enrolled
6 mo
75% freedom of AF at 6 mo follow-up post concomitant RFA. The AF burden decreased from 56.2% post-operatively to 27.5% at 6 mo post-operatively. 13% of patients had asymptomatic AF episodes identified via continuous monitoring
Concomitant RFA successfully reduces AF burden but based on these results, the importance of post-operative antiarrhythmic medication and anticoagulation should be evaluated
Table 8 Summary of results from studies included looking at high intensity focused ultrasound
Two-year follow-up of 28 people with paroxysmal AF 9 (n = 19) and persistent AF (n = 9) undergoing
Median follow-up 738 d
Following a median follow-up of 738 d, 79% of patients were free of AF. Following a repeat procedure with radiofrequency ablation, 18% of patients maintained freedom of AF
Success rates of HIFU are comparable to radiofrequency ablation but complication rates remain higher for HIFU
15 patients with AF refractory to antiarrhythmic medication underwent HIFU for PVI
24 mo
At 6 mo 40% of patients with 1 epicardial PVI gained sinus rhythm. After 1.3 ± 0.6 yr, 27% of patients had sinus rhythm after 1 epicardial pulmonary vein isolation
Success rate was low in epicardial pulmonary vein isolation done through right-sided VATS using HIFU and was associated with substantial complications
Systematic review of 37 studies with a total of 1877 patients
12 mo
Operative mortality for the Cox-Maze, epicardial ablation and hybrid approach were 0%, 0.5% and 0.9% At 12 mo, rates of sinus rhythm restoration for the above were 93%, 80% and 70% respectively
The Cox-Maze procedure with cardiopulmonary bypass revealed the highest success rate 12 mo post-procedure compared to the hybrid approach and epicardial approach
Citation: Kyprianou K, Pericleous A, Stavrou A, Dimitrakaki IA, Challoumas D, Dimitrakakis G. Surgical perspectives in the management of atrial fibrillation. World J Cardiol 2016; 8(1): 41-56